Mass treatment with azithromycin for trachoma control: participation clusters in households.
<h4>Background</h4>Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential.<h4>Methodology/principal...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe4b02fa4f8243d9b95d27742b2c3566 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fe4b02fa4f8243d9b95d27742b2c3566 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fe4b02fa4f8243d9b95d27742b2c35662021-11-18T09:13:47ZMass treatment with azithromycin for trachoma control: participation clusters in households.1935-27271935-273510.1371/journal.pntd.0000838https://doaj.org/article/fe4b02fa4f8243d9b95d27742b2c35662010-10-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20957196/pdf/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential.<h4>Methodology/principal findings</h4>As part of the Partnership for Rapid Elimination of Trachoma (PRET), 32 communities in Tanzania, and 48 in The Gambia had a detailed census taken followed by mass treatment with azithromycin. The target coverage in each community was >80% of children ages <10 years. Community treatment assistants observed treatment and recorded compliance, thus coverage at the community, household, and individual level could be determined. Within each community, we determined the actual proportions of households where all, some, or none of the children were treated. Assuming the coverage in children <10 years of the community was as observed and non-participation was at random, we did 500 simulations to derive expected proportions of households where all, some, or none of the children were treated. Clustering of household treatment was detected comparing greater-than-expected proportions of households where none or all of children were treated, and the intraclass correlation (ICC) was calculated. Tanzanian and Gambian mass treatment coverages for children <10 years of age ranged from 82-100% and 62-99%, respectively. Clustering of households where all children were treated or no children were treated was greater than expected. Compared to model simulations, all Tanzanian communities and 44 of 48 (91.7%) Gambian communities had significantly higher proportions of households where all children were treated. Furthermore, 30 of 32 (93.8%) Tanzanian communities and 34 of 48 (70.8%) Gambian communities had a significantly elevated proportion of households compared to the expected proportion where no children were treated. The ICC for Tanzania was 0.77 (95% CI 0.74-0.81) and for The Gambia was 0.55 (95% CI 0.51-0.59).<h4>Conclusions/significance</h4>In programs aiming for high coverage, complete compliance or non-compliance with mass treatment clusters within households. Non-compliance cannot be assumed to be at random.Elizabeth N SsemandaBeatriz MunozEmma M Harding-EschTansy EdwardsHarran MkochaRobin L BaileyAnsumana SillahDianne StareDavid C W MabeySheila K WestPRET Project TeamPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 4, Iss 10 (2010) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Elizabeth N Ssemanda Beatriz Munoz Emma M Harding-Esch Tansy Edwards Harran Mkocha Robin L Bailey Ansumana Sillah Dianne Stare David C W Mabey Sheila K West PRET Project Team Mass treatment with azithromycin for trachoma control: participation clusters in households. |
description |
<h4>Background</h4>Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential.<h4>Methodology/principal findings</h4>As part of the Partnership for Rapid Elimination of Trachoma (PRET), 32 communities in Tanzania, and 48 in The Gambia had a detailed census taken followed by mass treatment with azithromycin. The target coverage in each community was >80% of children ages <10 years. Community treatment assistants observed treatment and recorded compliance, thus coverage at the community, household, and individual level could be determined. Within each community, we determined the actual proportions of households where all, some, or none of the children were treated. Assuming the coverage in children <10 years of the community was as observed and non-participation was at random, we did 500 simulations to derive expected proportions of households where all, some, or none of the children were treated. Clustering of household treatment was detected comparing greater-than-expected proportions of households where none or all of children were treated, and the intraclass correlation (ICC) was calculated. Tanzanian and Gambian mass treatment coverages for children <10 years of age ranged from 82-100% and 62-99%, respectively. Clustering of households where all children were treated or no children were treated was greater than expected. Compared to model simulations, all Tanzanian communities and 44 of 48 (91.7%) Gambian communities had significantly higher proportions of households where all children were treated. Furthermore, 30 of 32 (93.8%) Tanzanian communities and 34 of 48 (70.8%) Gambian communities had a significantly elevated proportion of households compared to the expected proportion where no children were treated. The ICC for Tanzania was 0.77 (95% CI 0.74-0.81) and for The Gambia was 0.55 (95% CI 0.51-0.59).<h4>Conclusions/significance</h4>In programs aiming for high coverage, complete compliance or non-compliance with mass treatment clusters within households. Non-compliance cannot be assumed to be at random. |
format |
article |
author |
Elizabeth N Ssemanda Beatriz Munoz Emma M Harding-Esch Tansy Edwards Harran Mkocha Robin L Bailey Ansumana Sillah Dianne Stare David C W Mabey Sheila K West PRET Project Team |
author_facet |
Elizabeth N Ssemanda Beatriz Munoz Emma M Harding-Esch Tansy Edwards Harran Mkocha Robin L Bailey Ansumana Sillah Dianne Stare David C W Mabey Sheila K West PRET Project Team |
author_sort |
Elizabeth N Ssemanda |
title |
Mass treatment with azithromycin for trachoma control: participation clusters in households. |
title_short |
Mass treatment with azithromycin for trachoma control: participation clusters in households. |
title_full |
Mass treatment with azithromycin for trachoma control: participation clusters in households. |
title_fullStr |
Mass treatment with azithromycin for trachoma control: participation clusters in households. |
title_full_unstemmed |
Mass treatment with azithromycin for trachoma control: participation clusters in households. |
title_sort |
mass treatment with azithromycin for trachoma control: participation clusters in households. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2010 |
url |
https://doaj.org/article/fe4b02fa4f8243d9b95d27742b2c3566 |
work_keys_str_mv |
AT elizabethnssemanda masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT beatrizmunoz masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT emmamhardingesch masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT tansyedwards masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT harranmkocha masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT robinlbailey masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT ansumanasillah masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT diannestare masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT davidcwmabey masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT sheilakwest masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds AT pretprojectteam masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds |
_version_ |
1718421002575151104 |